a leading cannabis cultivator in Canada. More information can be found on [Greenway.ca] and updates can be followed on [Instagram], [Twitter], [Facebook], and [LinkedIn].The CSE has in no way passed upon the merits of the business of the Company and has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.Cautionary Note Regarding Forward-Looking StatementsThis news release contains forward-looking statements that constitute for ...

Core Insights - iAnthus Capital Holdings, Inc. is making significant progress in retail expansion, brand development, and capital structure initiatives in the cannabis industry [1] Retail Expansion - The Company plans to open its 26th GrowHealthy dispensary in Tequesta, Florida, on or about March 27, 2026, pending regulatory approvals, to enhance patient access in Palm Beach County [2] - The Tequesta dispensary aims to provide convenient access to high-quality cannabis products and is designed to meet the diverse wellness needs of the local community [3][4] Brand Development - In New Jersey, iAnthus has expanded its brand, The Vault, which features a curated archive of cannabis genetics aimed at resonating with distinct consumer segments [5] Capital Structure Initiatives - iAnthus, along with its subsidiary iAnthus New Jersey, LLC, has entered into amending agreements with related-party lenders to amend the terms of senior secured bridge notes issued on February 2, 2021 [6] - The maturity date of the Bridge Notes has been extended from February 16, 2026, to June 24, 2027, with an amendment fee of 2% of the principal amount, which is approximately US$8.4 million as of February 16, 2026 [7][8]

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting As filed with the Securities and Exchange Commission on January 26, 2026 Washington, D.C. 20549 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Akanda Corp. c/o Gowling WLG (Canada) LLP 100 King St. W, Suite 1600 Toronto, ON M5X 1G5, Canada Tel: +1 (4 ...

Summary of NewLake Capital Partners Conference Call Company Overview - **Company**: NewLake Capital Partners (OTCPK:NLCP) - **Type**: Net lease REIT focused exclusively on the cannabis industry - **Founded**: Nearly seven years ago - **Investment**: Deployed almost $500 million into the cannabis sector - **Portfolio**: Owns 34 properties across 12 states with 13 different tenants - **Weighted Average Yield**: 13% [4][5] Financial Position - **Leverage**: Nearly unlevered with only $7 million in credit facility debt - **Cash Position**: Net cash position, unusual for a REIT - **Average Lease Term**: Over 12 years remaining [5] - **Dividend Growth**: Nearly 80% growth since IPO in 2021, consistent dividend of $0.43 per share [5][20] Industry Insights - **Cannabis Market Size**: Estimated to be around $34-$35 billion in 2025 for the state-legal industry; overall cannabis industry (including illicit market) believed to exceed $100 billion [7][9] - **Growth Drivers**: Transition of medical states to adult-use markets, evolving medical programs, and changing consumer preferences, particularly among younger cohorts [8][10] - **Legislative Changes**: Potential rescheduling of cannabis from Schedule I to Schedule III, which would eliminate onerous tax consequences (IRS 280E) and enhance cash flow for operators [11][12] Portfolio Strategy - **Focus on Limited License States**: Targeting states with limited licenses to enhance margins and credit quality [16][17] - **Tenant Quality**: Emphasis on understanding tenant financials and management quality, with a focus on their ability to raise capital [15] - **Top Tenants**: Includes leading companies like Curaleaf, Cresco Labs, and Trulieve, which represent over 50% of the portfolio [19][20] Market Dynamics - **State-Level Growth**: States like Texas and Kentucky are expected to see significant growth in medical marijuana programs, requiring substantial real estate investment [35][36] - **Federal Regulation Impact**: Anticipated changes in federal regulations could lead to increased competition from traditional banks, but NewLake believes its niche focus will protect its market position [31][33] Risk Management - **Tenant Health**: Monitoring tenant performance closely; recent issues with Ayr Wellness led to property turnover, but proactive measures are in place for re-tenanting [25][26] - **Payout Ratio**: Maintains an 82% payout ratio, allowing for absorption of potential vacancies without impacting dividends [22][23] Competitive Landscape - **Comparison with Peers**: NewLake differentiates itself from larger peers like Innovative Industrial Properties by focusing on limited license states and property-level cash flows, which has resulted in better tenant retention [40][41] Future Outlook - **Capital Allocation**: Strong balance sheet allows for continued investment without the need for equity dilution; share buybacks are considered when advantageous [38][39] - **Market Opportunities**: Significant room for growth in the cannabis sector, particularly as more states adopt adult-use legislation and the federal government regulates the market [37] This summary encapsulates the key points discussed during the NewLake Capital Partners conference call, highlighting the company's strategic focus, financial health, industry dynamics, and future growth potential.

Core Insights - Canopy Growth's stock is trading at less than $2, raising questions about its attractiveness as an investment given the current market conditions [1] Group 1: Market Performance - Canopy Growth is one of the largest cannabis producers in Canada, with a diverse product portfolio including dried cannabis, vapes, and cannabis-infused drinks [3] - The Canadian cannabis market has been disappointing, with limited growth opportunities, significant competition, and ongoing legal and regulatory challenges affecting all Canadian cannabis companies [4] - The overall cannabis industry in Canada has experienced slow revenue growth and consistent net losses, indicating systemic issues rather than company-specific problems [5] Group 2: U.S. Market Dynamics - Recent developments in the U.S. cannabis market, such as the reclassification of cannabis by President Trump, may improve conditions for U.S. cannabis companies but are unlikely to benefit Canopy Growth significantly [5][6] - Cannabis remains illegal at the federal level in the U.S., creating challenges for companies, including high operational costs and difficulties in profitability [7] - Canopy Growth's U.S. subsidiary will face intense competition, similar to what it experiences in Canada, limiting its potential for recovery [7]

Core Insights - Glass House Brands Inc. is collaborating with the University of California Berkeley to advance research in the cannabis and hemp sectors, focusing on medicinal cannabinoids and crop yield variability [2][4]. Group 1: Partnership and Research Objectives - The partnership aims to identify development needs in the cannabis sector and assess research capacity at the university [2]. - A recent award of approximately $1,800,000 from the California Department of Cannabis Control (DCC) will fund a project titled "Cannabis Crop Yields: Survey & Remote Sensing" [2]. - The project will estimate cannabis crop yield variability across different cultivation systems, which is expected to enhance crop-production estimates and regulatory oversight [2][3]. Group 2: Research Methodology and Expected Outcomes - The research will analyze growth rates and yields across various cultivation methods, including greenhouse and outdoor systems, using grower surveys and remote sensing techniques [3]. - Findings from the research are anticipated to inform policymakers and growers, contributing to discussions on agricultural innovation and sustainability in California [5]. Group 3: Company Commitment and Vision - Glass House Brands emphasizes its commitment to data-driven insights that can benefit the regulated cannabis market [4]. - The company aims to improve efficiency, sustainability, and quality in cannabis production through this research collaboration [5]. - Glass House is recognized as one of the fastest-growing, vertically integrated cannabis companies in the U.S., focusing on building strong brands and serving consumers across California [6].

Core Insights - Greenway Greenhouse Cannabis Corporation experienced significant operational and strategic progress in 2025, focusing on disciplined execution, efficiency gains, and international expansion [1][2] Operational Performance and Efficiency - The company maximized output and consistency across its 2.5 acres of active cultivation, achieving improved yields and tighter cost controls through better crop scheduling, strain selection, and facility utilization [3] - Management believes that the operational improvements represent a durable step-change in efficiency, forming the backbone of the company's profitability strategy [4] International Sales Pipeline Development - Greenway advanced its international wholesale program, successfully entering multiple jurisdictions in Europe and Australia, reflecting the quality of its cultivation output and compliance with global medical cannabis market requirements [5] - A strategic supply agreement with 4C Labs was established to serve the U.K. medical cannabis market, complementing the company's broader global sales footprint [6] - The company expects international wholesale to remain a key focus area as it builds commercial relationships to meet growing demand in regulated markets [7] Next Phase of Growth - Greenway is positioned to increase output by over 75% using existing built-out capacity without significant capital expenditures, allowing for measured production increases [8] - As international sales channels develop, the company anticipates that utilizing this capacity will drive higher production volumes and top-line revenue growth while maintaining a disciplined cost structure [9] Financial Performance - In 2025, Greenway achieved a 20% increase in total revenue and improved its average selling price per gram by over 40%, indicating stronger demand and product quality [10][11] - The company aims to utilize its existing cultivation capacity to increase output without negatively impacting its cost structure, thereby enhancing profitability [12] Market Outlook - Despite ongoing pricing pressure and structural changes in the cannabis sector, Greenway's focus on execution, capital discipline, and international diversification has insulated it from severe market disruptions [13]

Core Insights - Village Farms International, Inc. has appointed Brian Stevenson as the Global Chief Strategy Officer to lead the company's strategic agenda focused on long-term growth and global market assessment [1][4] - The appointment reflects the company's commitment to disciplined global expansion and long-term value creation in regulated markets, particularly in cannabis [4] Company Overview - Village Farms is a large-scale, vertically-integrated supplier of high-value, plant-based Consumer Packaged Goods, leveraging decades of experience in Controlled Environment Agriculture [5] - The company has a strong foundation as a leading fresh produce supplier in the US and Canada, now focusing on high-growth cannabinoid opportunities while maintaining its produce assets [5] Cannabis Operations - In Canada, Village Farms operates Pure Sunfarms, one of the largest cannabis operations globally, with 2.2 million square feet of greenhouse production and plans for future expansion with an additional 2.6 million square feet [6] - The company owns 80% of Rose LifeScience, a leader in cannabis product commercialization in Quebec [6] International Expansion - Village Farms is targeting legal cannabis opportunities internationally, exporting medical cannabis from its EU GMP certified facility in Canada to markets such as Germany, the UK, Israel, Australia, and New Zealand [7] - The company is expanding its export business and making investments in international production assets, including a license to grow and distribute recreational cannabis in the Netherlands [7] US Market Strategy - In the US, Village Farms' subsidiary Balanced Health Botanicals is a leading CBD and hemp-derived brand, with plans to enter the US THC market leveraging its Texas-based greenhouse assets [8][9] - The company has 2.2 million square feet of existing greenhouse capacity and 950 acres of owned land for future expansion in the US [9] Renewable Energy Initiatives - Village Farms Clean Energy, in partnership with Terreva Renewables, generates renewable natural gas from landfill gas, receiving royalties on all generated revenue [9]

Core Viewpoint - Cronos Group Inc. is acquiring CanAdelaar B.V. for an up-front cash consideration of US$67.0 million, plus additional cash earnouts based on normalized EBITDA for 2026 and 2027, positioning Cronos as the market leader in the Netherlands' adult-use cannabis market [1][2]. Transaction Overview - The acquisition involves an up-front payment of €57.5 million (US$67.0 million), representing approximately 1.4 times CanAdelaar's last twelve months (LTM) revenue and 2.4 times LTM EBITDA [1][8]. - The transaction is expected to close in early 2026, pending regulatory approvals in the Netherlands [9]. Strategic Rationale - The acquisition is seen as financially compelling and strategically important for establishing a footprint in Europe and leveraging investments in borderless products [2][12]. - CanAdelaar is the largest cannabis company in the Netherlands' adult-use cannabis pilot program, known as the Wietexperiment, which is designed to create a regulated cannabis supply chain [3][4]. Market Context - The Wietexperiment was enacted in 2020 and officially launched in April 2025, allowing for the sale of cannabis in ten municipalities, with the potential for expansion [3][12]. - CanAdelaar has a current cultivation yield of approximately 20,000 kg of dried flower annually and is the only industrial-scale greenhouse cultivator in the Wietexperiment [6][12]. Financial Performance - CanAdelaar's revenue is projected to grow from US$17.7 million in 2024 to US$47.3 million for the twelve months ending September 30, 2025 [6]. - EBITDA is expected to increase from US$8.0 million in 2024 to US$28.2 million for the twelve months ending September 30, 2025 [7]. Competitive Positioning - CanAdelaar holds the leading market share within the Wietexperiment, with active sales to nearly all 72 coffee shops involved in the program [5][12]. - The regulatory framework of the Wietexperiment is designed to promote responsible adult use, potentially serving as a model for other countries [12].

Core Insights - FLUENT Corp. has rebranded its Manhattan and White Plains dispensaries, marking the second and third adult-use locations in New York under the FLUENT brand [1][3] - The rebranding follows FLUENT's acquisition of RIV Capital and aims to enhance the company's presence in the rapidly growing adult-use cannabis market in the U.S. [3] Group 1: Rebranding and Market Strategy - The rebranding of the three dispensaries is expected to drive positive results in traffic, sales volume, and average ticket sales [3] - FLUENT is committed to creating a consistent and trusted retail experience across its locations, which is crucial for its New York strategy [4] - The company is preparing for the first harvest from its new indoor cultivation facility in Buffalo, with premium flower expected to be available in Q4 [4] Group 2: Digital Integration and Product Offerings - All three rebranded dispensaries are fully integrated into FLUENT's digital platform, allowing customers to browse products and place orders online [4] - The dispensaries feature FLUENT's premium cannabis brands, including MOODS, Knack, Wandr, Alien Labs, and Connected Cannabis [6][7] Group 3: Company Overview - FLUENT is a national cannabis consumer packaged goods company operating in Florida, New York, Pennsylvania, and Texas, with a focus on operational excellence [7] - The company employs 700 staff across 8 cultivation and manufacturing facilities and has 42 active retail locations [7] - FLUENT's common shares trade on the Canadian Securities Exchange and the OTCQB Venture Market [8]